Playback speed
10 seconds
ESMO 2020 Updates on NSCLC: 1L Cemiplimab vs. Platinum-Doublet Chemo in Advanced Disease, Atezo + Bev for High PD-L1 Non-Sq Disease, 1L Nivo + Carboplatin/Paclitaxel/Bev for Advanced/Recurrent Non-Sq Disease
253 views
January 5, 2021
Login to view comments.
Click here to Login